Akamai Technologies Inc. Stock Slides 6.5%, Underperforms Peers
Dow Jones2026/11/02 21:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Akamai Technologies Inc. slipped 6.5% to $86.69 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,983.98 and the S&P 500 Index falling 0.5% to 7,541.40.
This was the stock's second consecutive day of losses.
Akamai Technologies Inc. closed 47.6% below its 52-week high of $165.45, which the company reached on May 13th.
The stock underperformed when compared to some of its peers, as Synopsys Inc. fell 0.3% to $466.08, Cognizant Technology Solutions Corp. remained unchanged, and Arista Networks Inc. fell 2.80% to $164.14.
Trading volume totaled 4.1 million, compared to the 50-day average of 4.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 02, 2026 16:35 ET (21:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
